PV patients lacking the JAK2-p.V617F mutation often display activating mutations in exon 12 or in 1% and 5% of the cases in MPL patients, respectively (Pikman et al., 2006; Scott et al., 2007). This evidence concerns the gene JAK2 and acquired polycythemia vera.